Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ohio State University Comprehensive Cancer Center

Clinical trials sponsored by Ohio State University Comprehensive Cancer Center, explained in plain language.

Trials to join now! 62 Not yet recruiting 9 Not yet finished but already full! 35 Completed 32 Terminated 1

Experimental combo for rare blood cancer shows promise but trial halted early

Disease control Terminated

This early-phase trial tested a combination of two drugs—ruxolitinib and CPX-351—in 12 people with advanced myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The goal was to find the best dose and see if the combo could shrink cancer. However, the study was stop…

Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC